Exploding medical costs
Proposes changing the cost structure at its root by raising the cell's capacity for self-recovery.
01 / SOCIAL PROBLEMS
From medicine that suppresses symptoms to a path that revives the cell's own capacity to recover. Thirteen problems GRBM targets in medicine, public health and metabolic disease.
In plain words
Medical spending grows every year worldwide, yet chronic and intractable diseases do not decline. Conventional medicine divides the body by organ and stays focused on suppressing symptoms.
GRBM takes another path. Instead of attacking a single target like a drug, it supplies metabolites that cells can use directly, gives the body metabolic rest, and helps it reorganize itself. I call this metabolic realignment.
This is not about avoiding medicine. It is about changing the order. First help the body recover by itself; then let medicine do its job on a recovered body.
Proposes changing the cost structure at its root by raising the cell's capacity for self-recovery.
Researches a new, non-surgical, non-toxic approach that creates the conditions for recovery.
Focuses on Bacteriocin (Plantaricin), a natural antimicrobial from plant lactic acid bacteria.
Approaches it through thymic reactivation and the re-education of regulatory T cells (Tregs).
Continued observation from the perspective of gut–brain axis recovery and β-amyloid clearance.
Re-examines aging through the "reversible aging response" of intron expression and telomeres.
Restoring neurotransmitter balance and the gut–brain axis to regain mental vitality.
6 million in Korea, 500 million worldwide. Approaches the root cause as a reprogramming of cellular metabolism.
Approached through vascular-cell recovery and reduced inflammation.
Proposes breaking the cycle by normalizing fat metabolism.
Answers the triple burden of obesity, depression and medical bankruptcy by restoring the gut ecosystem.
Protects the metabolic health of an overworked generation with an everyday GRBM routine.
Everyday bio-food for a generation whose eating habits have collapsed.
Most foods, supplements and drugs can only be broken down, converted, absorbed and used when the digestive system and enzymes work well. But enzymes are proteins produced by gene expression, and their activity falls with age, disease and stress. So the same substance works poorly for the elderly and the sick.
Because GRBM has already been metabolized by the plant and its lactic acid bacteria, it aims to be a metabolome that requires no digestion and does not depend on enzymes. That is why it matters most for babies, patients and the elderly, whose digestion is weakest.
| Item | Conventional approach | GRBM approach |
|---|---|---|
| Perspective | Divides by organ and disease | Sees the whole body as one ecosystem (Holobiont) |
| Method | Suppresses or attacks a target | Gives metabolic rest so the body realigns itself |
| Condition | Depends on enzymes and digestion | Aims at metabolites cells use directly |
| Process | Relies on heat and chemistry | Non-heat, non-chemical ecological process |
| Burden | Extra metabolic load, possible side effects | Reduced metabolic load, tissue rest |
Chemically synthesized drugs can produce mirror-image "twin molecules" (isomers), and while one twin treats a symptom, the other may cause side effects elsewhere. After 20 years of research I concluded that the right order is to help the body recover first, and then let drugs add the functions still needed.
a process without heat or chemicals
genetic signals such as External miRNA
already-metabolized nutrition
then medicine does its part
Source: the developer's (Wooyoung Nam's) research. GRBM does not replace standard care; disease-specific effects will be published through clinical papers and independent verification.
PARTNERSHIP · INVESTMENT
After signing an NDA you can review the materials, then verify the original records and the process in person during on-site due diligence in Uljin, Gyeongsangbuk-do, Korea.